BPCIA Complaint Against Proposed Rituxan® Biosimilar DR

On November 17, 2023, Genentech, Inc., Hoffmann-La Roche Inc., and Biogen Inc. ("Plaintiffs") filed a BPCIA complaint ("Complaint") against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories SA ("DRL SA")...

Related Keywords

United States , New Jersey , Fresenius Kabi Deutschland Gmb , April Breyer Menon , Sandoz Gmb , Sanofi Aventis Deutschland Gmb , Fresenius Kabi Swissbiosim , Roche Inc , Fresenius Kabi United States , Celltrion Healthcare Co Ltd , Reddy Laboratories Inc , Genentech , Celltrion Healthcare Co , Biogen Inc , Biogen Idec Inc , Genentech Inc , Hoffmann La Roche Inc , Fresenius Kabi Deutschland Gmbh , Sanofi Aventis Deutschland Gmbh , Commercial Marketing , Mondaq , Bpcia Complaint Against Proposed Rituxan Xae Biosimilar Drl Ri Filed , Food , Drugs , Healthcare , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property , Patent , ,